Metastatic Melanoma Clinical Trials in Madison, Wisconsin

4 studies are recruiting for metastatic melanoma in Madison, Wisconsin right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

   This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

   Locations

   331 in total

   Run by

   SWOG Cancer Research Network

   See if you can join NCT04511013 on ClinicalTrials.gov

2. Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

   This study is being done to see if combining HEPZATO KIT™ with nivolumab and relatlimab (Opdualag™) in patients with metastatic melanoma with liver metastasis is safe, tolerable, and will have a synergistic effect leading to improved clinical outcomes compared to the historic cohort of patients wit…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UW Hospital and Clinics, Madison, Wisconsin

   Run by

   University of Wisconsin, Madison

   See if you can join NCT07281924 on ClinicalTrials.gov

3. MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

   In this first-in human, phase I/IIa study, the safety and efficacy of [212Pb]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluated as a monotherapy and in combination with nivolumab in subjects with unresectable and metastatic mel…

   Stage

   Phase 1

   Ages

   18 to 90

   Site

   University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

   Locations

   13 in total

   Run by

   Perspective Therapeutics

   See if you can join NCT05655312 on ClinicalTrials.gov

4. In Vivo Liquid Biopsy of Melanoma (Cytophone)

   The Cytophone is a first in the world patented system to identify and count single circulating melanoma cells in blood circulation inside the human body. The Cytophone has a unique capability to find rare melanoma cells in the blood by an assessment of 100-500 times greater amounts of blood volume …

   Stage

   Not phased

   Ages

   18 to 80

   Site

   SSM Health Dean Medical Group Specialty Services, Madison, Wisconsin

   Run by

   Cytoastra

   See if you can join NCT06488365 on ClinicalTrials.gov